4-aminopyridine and ergoline

4-aminopyridine has been researched along with ergoline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowyer, JF; Weiner, N1
Barrett, JE; Rosenzweig-Lipson, S1
O'Malley, KL; Tang, L; Todd, RD1

Other Studies

3 other study(ies) available for 4-aminopyridine and ergoline

ArticleYear
K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Aminopyridines; Animals; Calcium; Colforsin; Dopamine; Ergolines; Ethylmaleimide; In Vitro Techniques; Pertussis Toxin; Potassium Channels; Quinpirole; Rats; Synaptosomes; Tetraethylammonium Compounds; Virulence Factors, Bordetella

1989
K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.
    Pharmacology, biochemistry, and behavior, 1995, Volume: 51, Issue:4

    Topics: 4-Aminopyridine; Amodiaquine; Animals; Apamin; Behavior, Animal; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Potassium Channels; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Saimiri

1995
Dopamine D2 and D3 receptors inhibit dopamine release.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:2

    Topics: 4-Aminopyridine; Animals; Cell Line; Dopamine; Ergolines; Humans; Membrane Potentials; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Tetraethylammonium; Tetraethylammonium Compounds

1994